TECENTRIQ: FIRST FDA-APPROVED ADJUVANT CANCER IMMUNOTHERAPY FOR STAGE II TO IIIA PD-L1+ NSCLC

When:  Sep 8, 2022 from 17:30 to 20:00 (ET)
Associated with  North Carolina Triangle

Location

Bin 54
1201 Raleigh Rd
Chapel Hill, NC 27517